121 related articles for article (PubMed ID: 8385525)
1. Differences in the acute and chronic antihypertensive effects of lisinopril and enalapril assessed by ambulatory blood pressure monitoring.
Gourlay S; McNeil J; Forbes A; McGrath B
Clin Exp Hypertens; 1993 Jan; 15(1):71-89. PubMed ID: 8385525
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
[TBL] [Abstract][Full Text] [Related]
3. First-dose blood pressure response in mild-to-moderate heart failure: a randomized, double-blind study comparing enalapril with lisinopril by 24-hour noninvasive blood pressure monitoring.
Otterstad JE; Froeland G
Am J Cardiol; 1992 Oct; 70(10):132C-134C. PubMed ID: 1329468
[No Abstract] [Full Text] [Related]
4. Comparison of treatment with lisinopril versus enalapril for congestive heart failure.
Zannad F; van den Broek SA; Bory M
Am J Cardiol; 1992 Oct; 70(10):78C-83C. PubMed ID: 1329478
[TBL] [Abstract][Full Text] [Related]
5. Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring.
Diamant M; Vincent HH
J Hum Hypertens; 1999 Jun; 13(6):405-12. PubMed ID: 10408591
[TBL] [Abstract][Full Text] [Related]
6. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures.
Whelton A; Miller WE; Dunne B; Hait HI; Tresznewsky ON
J Clin Pharmacol; 1990 Dec; 30(12):1074-80. PubMed ID: 2177062
[TBL] [Abstract][Full Text] [Related]
7. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
Motero Carrasco J
Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
[TBL] [Abstract][Full Text] [Related]
8. Lisinopril and enalapril in hypertension: a comparative study using ambulatory monitoring.
Conway J; Coats AJ; Bird R
J Hum Hypertens; 1990 Jun; 4(3):235-9. PubMed ID: 2163450
[TBL] [Abstract][Full Text] [Related]
9. Different hemodynamic (24-h ambulatory blood pressure monitoring) and renin-inhibiting effect of a 1-week treatment with enalapril and lisinopril.
Cocco G; Hari J
Clin Cardiol; 1991 Nov; 14(11):881-4. PubMed ID: 1662562
[TBL] [Abstract][Full Text] [Related]
10. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
[TBL] [Abstract][Full Text] [Related]
11. A comparison of single doses of lisinopril and enalapril in hypertension.
Dews I; Wiseman WT; al-Khawaja I; Stephens J; VandenBurg M
J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive efficacy of lisinopril. Ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schwartz GL; Schirger A; Ilstrup DM; Long CR; Carlson CA
Am J Hypertens; 1988 Jul; 1(3 Pt 3):274S-279S. PubMed ID: 2843199
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, parallel comparative study of the antihypertensive efficacy of once-daily lisinopril vs enalapril with 24-h ambulatory blood pressure monitoring in essential hypertension.
Coca A; Sobrino J; Módol J; Soler J; Mínguez A; Plana J; De la Sierra A
J Hum Hypertens; 1996 Dec; 10(12):837-41. PubMed ID: 9140792
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients.
Vaur L; Dutrey-Dupagne C; Boussac J; Genes N; Bouvier d'Yvoire M; Elkik F; Meredith PA
J Cardiovasc Pharmacol; 1995 Jul; 26(1):127-31. PubMed ID: 7564352
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study.
Tomei R; Rossi L; Carbonieri E; Franceschini L; Molon G; Zardini P
J Cardiovasc Pharmacol; 1992 Jun; 19(6):911-4. PubMed ID: 1376812
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.
Herpin D; Conte D
J Hum Hypertens; 1989 Jun; 3 Suppl 1():11-5. PubMed ID: 2550634
[TBL] [Abstract][Full Text] [Related]
17. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
Pechère-Bertschi A; Nussberger J; Decosterd L; Armagnac C; Sissmann J; Bouroudian M; Brunner HR; Burnier M
J Hypertens; 1998 Mar; 16(3):385-93. PubMed ID: 9557932
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
Wallis EJ; Ramsay LE; Hettiarachchi J
Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
